Crow Point Partners’s Neurocrine Biosciences NBIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,776	Closed	-$218K	–	144
2018 Q3	$218K	Buy	+1,776	New	+$218K	0.04%	138
2018 Q2	–	Sell	-2,728	Closed	-$226K	–	197
2018 Q1	$226K	Buy	2,728 +810	+42%	+$67.1K	0.04%	95
2017 Q4	$145K	Buy	+1,918	New	+$145K	0.02%	147